It was a wish from both sides, and an understanding that we needed to go fast because… the story was a great one, so that’s why it was intense—it was a common understanding that it was important to join forces… and be fast…. this is also part of the reason why I approached Jennifer Doudna… we were very much in line in the way to do very precise research…. it was fast but precise, and deep. For this we recognized one another—we are the same type of scientist who… want to see the details of the data, so this was… important because… this is not about a paper published in… the high impact-factor journals. It’s really about… solid work.
Emmanuelle Charpentier quote
Advertisement
More from Emmanuelle Charpentier
-
First of all, CRISPR-Cas has facilitated a lot, and genetics in research and development. But as to have it as a technology that can be used safely for the editing of the human germline it’s something else, first of all. And second of all one should not underestimate that fact that CRISPR-Cas9, even though it is a wonderful tool, it would be extremely difficult to get the technology to modify more than one gene at a time. So I think, let’s say, indeed unfortunately we may see unfortunate and really unwanted experiments.
-
The field of CRISPR-Cas biology and engineering continues to evolve at a rapid pace, with great new developments emerging almost every week. The technology continues to evolve as well, with many new discoveries in basic biological research, with large-scale medical and biotechnology applications to come in the future.
-
One should be surrounded by people who can help. We are all sitting in the same boat.
-
Personally, I don't think it is acceptable to manipulate the human germline for the purpose of changing some genetic traits that will be transmitted over generations.
-
As long as they are not perfect and ready, I think it's good to have this ban against editing the germline.
-
We continue to work in a humble way on the specific mechanisms existing in bacteria, so we can identify therapeutic targets and have new antibiotics ready to combat future infections.